Overview

Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects

Status:
Completed
Trial end date:
2006-12-15
Target enrollment:
Participant gender:
Summary
This study was designed to look at safety aspects and effects of repeat inhaled doses of GW870086X in mild asthmatics to develop this drug for its use in asthma and chronic obstructive pulmonary disease (COPD)
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline